Milkyway2026 is the privately held patent portfolio of Michael Scheller at the convergence of AI breath diagnostics, MPCVD diamond synthesis, and precision instrumentation — developed from Trasadingen, Switzerland, with partners in Surat, Gujarat and Marseille, France.
AI-enabled breath analyzer for symptom-agnostic TB point-of-care screening in India.
SURAT-7B MPCVD reactor for Single Crystal Diamond synthesis · 6 kW GaN · 7-seed configuration.
Proprietary precision-instrumentation platform · built on the privately held Milkyway2026 patent (CH 000590/2026) — the base technology behind all three projects.